Geodezyjna ocena osiadań powierzchni terenu wokół kopalni Bogdanka w latach 1976-1983

An attempt to apply a measuring dynamic network model into land subsidence process evaluation is described in the presented essay. The surface subsidence process, occurring on rural areas around KWK Bogdanka, is suspected to be consequent upon orogen drainage, related to drilling of mining shafts. The elaboration of archival measuring data with the use of a dynamic model of measuring network enabled to extend the interpretation extension of the interpretation of the observed settlements process for potential drainage process parameters, affecting a specific rock deformation process.W artykule opisano próbę zastosowania dynamicznego modelu geodezyjnej sieci pomiarowo-kontrolnej do oceny procesu osiadania powierzchni terenów wiejskich wokół KWK Bogdanka, wywołanego odwodnieniem górotworu podczas drążenia szybów wydobywczych tej kopalni. Opracowanie archiwalnych materiałów pomiarowych z wykorzystaniem dynamicznego modelu sieci pomiarowej umożliwiło rozszerzenie interpretacji zaobserwowanego procesu osiadań na potencjalne parametry procesu odwodnienia, wpływające na konkretny przebieg procesu deformacji górotworu

Effect of starch binder on charcoal briquette properties

The paper shows the results of a study on the effect of starch binder on the mechanical, physical and burning properties of charcoal briquettes. Two types of binders were repeatedly used to make briquettes of native wheat starch and modified wheat starch, at 8% of the whole. Briquetting was performed in a roller press unit, and pillow-shaped briquettes were made. The moisture of the mixed material ranged from 28 to 32%. The product, whether the former or the latter, was characterized by very good mechanical properties and satisfactory physical properties. Moreover, the type of starch binder had no effect on toughness, calorific heating value, volatiles, fixed carbon content and ash content. However, the combustion test showed quite different burning properties. As briquettes should have short firing up time and lower smokiness, as well as high maximum temperature and long burning time, we have concluded that briquettes with native wheat starch as a binder are more appropriate for burning in the grill

Formation of Nitrogen Doped Titanium Dioxide Surface Layer on NiTi Shape Memory Alloy

NiTi shape memory alloys are increasingly being used as bone and cardiac implants. The oxide layer of nanometric thickness spontaneously formed on their surface does not sufficiently protect from nickel transition into surrounding tissues, and its presence, even in a small amount, can be harmful to the human organism. In order to limit this disadvantageous phenomenon, there are several surface engineering techniques used, including oxidation methods. Due to the usually complex shapes of implants, one of the most prospective methods is low-temperature plasma oxidation. This article presents the role of cathode sputtering in the formation of a titanium dioxide surface layer, specifically rutile. The surface of the NiTi shape memory alloy was modified using low-temperature glow discharge plasma oxidation processes, which were carried out in two variants: oxidation using an argon + oxygen (80% vol.) reactive atmosphere and the less chemically active argon + air (80% vol.), but with a preliminary cathode sputtering process in the Ar + N2 (1:1) plasma. This paper presents the structure (STEM), chemical composition (EDS, SIMS), surface topography (optical profilometer, Atomic Force Microscopy—AFM) and antibacterial properties of nanocrystalline TiO2 diffusive surface layers. It is shown that prior cathodic sputtering in argon-nitrogen plasma almost doubled the thickness of the produced nitrogen-doped titanium dioxide layers despite using air instead of oxygen. The (TiOxNy)2 diffusive surface layer showed a high level of resistance to E. coli colonization in comparison with NiTi, which indicates the possibility of using this surface layer in the modification of NiTi implants’ properties

Edoxaban versus warfarin in patients with atrial fibrillation

Contains fulltext : 125374.pdf (publisher's version ) (Open Access)BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years). The primary efficacy end point was stroke or systemic embolism. Each edoxaban regimen was tested for noninferiority to warfarin during the treatment period. The principal safety end point was major bleeding. RESULTS: The annualized rate of the primary end point during treatment was 1.50% with warfarin (median time in the therapeutic range, 68.4%), as compared with 1.18% with high-dose edoxaban (hazard ratio, 0.79; 97.5% confidence interval [CI], 0.63 to 0.99; P<0.001 for noninferiority) and 1.61% with low-dose edoxaban (hazard ratio, 1.07; 97.5% CI, 0.87 to 1.31; P=0.005 for noninferiority). In the intention-to-treat analysis, there was a trend favoring high-dose edoxaban versus warfarin (hazard ratio, 0.87; 97.5% CI, 0.73 to 1.04; P=0.08) and an unfavorable trend with low-dose edoxaban versus warfarin (hazard ratio, 1.13; 97.5% CI, 0.96 to 1.34; P=0.10). The annualized rate of major bleeding was 3.43% with warfarin versus 2.75% with high-dose edoxaban (hazard ratio, 0.80; 95% CI, 0.71 to 0.91; P<0.001) and 1.61% with low-dose edoxaban (hazard ratio, 0.47; 95% CI, 0.41 to 0.55; P<0.001). The corresponding annualized rates of death from cardiovascular causes were 3.17% versus 2.74% (hazard ratio, 0.86; 95% CI, 0.77 to 0.97; P=0.01), and 2.71% (hazard ratio, 0.85; 95% CI, 0.76 to 0.96; P=0.008), and the corresponding rates of the key secondary end point (a composite of stroke, systemic embolism, or death from cardiovascular causes) were 4.43% versus 3.85% (hazard ratio, 0.87; 95% CI, 0.78 to 0.96; P=0.005), and 4.23% (hazard ratio, 0.95; 95% CI, 0.86 to 1.05; P=0.32). CONCLUSIONS: Both once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes. (Funded by Daiichi Sankyo Pharma Development; ENGAGE AF-TIMI 48 ClinicalTrials.gov number, NCT00781391.)